U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07364318) titled 'Cognitive Function in Obstructive Sleep Apnea' on Nov. 14, 2025.
Brief Summary: Obstructive sleep apnea (OSA) is the most common sleep-related breathing disorder and has been increasingly recognized as a contributor to cognitive decline and a potential risk factor for neurodegeneration. Previous studies have identified several associated comorbidities, including vascular dysfunction, metabolic alterations, and neuroinflammatory changes. However, the impact and underlying interplay of these pathophysiological mechanisms remain poorly understood due to the lack of integrated, multidimensional assessment. This prospective, observationa...